Reproducibility of Dual Beam Doppler Fourier-domain Optical Coherence Tomography in Healthy Subjects

Launched by MEDICAL UNIVERSITY OF VIENNA · Jan 28, 2019

Keywords

ClinConnect Summary

This clinical trial is studying a new, non-invasive technique called Dual Beam Doppler Fourier-domain Optical Coherence Tomography (DOCT), which measures blood flow in the retina, the light-sensitive tissue at the back of the eye. Understanding how reliable these measurements are over time is important as researchers aim to improve this technique for future use in eye care.

To participate in the trial, individuals must be healthy men and women aged between 18 and 35, who do not smoke and have normal eye health. Participants should not be taking any regular medications or have any significant health issues in the three weeks before joining the study. If eligible, participants can expect to undergo a simple procedure that helps researchers learn more about how well this technology works in measuring eye blood flow. It’s a great opportunity to contribute to important research in eye health!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Men and women aged between 18 and 35 years
• • Non-smokers
• • Normal findings in the medical history unless the investigator considers an abnormality to be clinically irrelevant
• • Normal ophthalmic findings, ametropy \< 3 Dpt.
• Exclusion Criteria:
• • Regular use of medication, abuse of alcoholic beverages, participation in a clinical trial in the 3 weeks preceding the study
• • Treatment in the previous 3 weeks with any drug (except contraceptives)
• • Symptoms of a clinically relevant illness in the 3 weeks before the first study day
• • Blood donation during the previous 3 weeks
• • Pregnancy, planned pregnancy or lactating
• • History or family history of epilepsia